Aether Industries (AETHER) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
9 Jul, 2026Executive summary
Q4 FY25 revenue reached ₹2,453M, up 5% sequentially and 90% year-over-year, with EBITDA at ₹819M (+8% Q/Q, +469% Y/Y) and PAT at ₹504M (+16% Q/Q, +3621% Y/Y).
FY25 consolidated revenue was ₹8,803M (+38% Y/Y), EBITDA ₹2,709M (+72% Y/Y), and PAT ₹1,584M (+92% Y/Y).
Achieved 21% sequential and 34% year-over-year volume growth in Q4 and FY25, respectively.
Added six new clients in Q4 FY25 and 37 new customers in FY25, expanding market reach.
Consolidated and standalone financial statements for FY25 were audited and received unqualified opinions, confirming compliance with Ind AS.
Financial highlights
Q4 FY25 consolidated revenue: ₹2,453M; EBITDA margin: 33%; PAT margin: 21%.
FY25 consolidated revenue: ₹8,803M; EBITDA margin: 31%; PAT margin: 18%.
Standalone revenue for FY25: ₹7,885.18M; standalone PAT: ₹1,520.90M.
Cash and cash equivalents at FY25 end: ₹2,398M (down from ₹5,557M in FY24).
Basic and diluted EPS (consolidated) for FY25 was ₹11.95, up from ₹6.31 in FY24.
Outlook and guidance
Margins expected to remain stable around 29%-30% in FY26, with gradual improvement.
Site 5 phase one commissioning expected in H2 FY26; Site 3++ expansion with new US client to launch in Q4 FY26.
Working capital cycle targeted to reduce to 150 days over the next 2-3 years.
No forward revenue guidance, but strong growth anticipated from CRAMS and CEM.
Management is confident of settling insurance claims related to the fire incident in FY25-26.
Latest events from Aether Industries
- Q1 FY27 delivered 27% revenue growth, margin expansion, and major R&D and insurance milestones.AETHER
Q1 26/2731 Jul 2026 - Q3 FY26 revenue up 44% YoY, EBITDA up 75%, with strong growth and capacity expansions.AETHER
Q3 25/269 Jul 2026 - Q3 FY25 delivered strong revenue and profit growth, supported by expansion and new contracts.AETHER
Q3 24/258 Jul 2026 - Q1 FY26 revenue up 35% Y/Y, EBITDA up 94%, with major expansions and Milliken contract signed.AETHER
Q1 25/268 Jul 2026 - 38% revenue growth and strong EBITDA, with R&D expansion and insurance claims ongoing.AETHER
Q4 25/2630 Jun 2026 - Q1 FY25 delivered strong growth, margin recovery, and major capital raise approval.AETHER
Q1 24/252 Feb 2026 - Q2 and H1 FY25 delivered strong growth, robust margins, and ongoing expansion initiatives.AETHER
Q2 24/2519 Dec 2025 - Q2 FY26 delivered 38% revenue and 70% EBITDA growth, with CEM/CRAMS over 50% of sales.AETHER
Q2 25/2619 Dec 2025